Abstract
Ebstein anomaly comprises approximately 1% of all congenital heart diseases. It occurs when the tricuspid valve fails to properly delaminate from the right ventricle, resulting in a clinical spectrum of abnormal tricuspid valve morphology and right ventricular dysfunction. Due to the anatomy of the tricuspid valve and right ventricle, as well as associated right- and left-sided pathology, patients are at risk for both right and left ventricular failure and the associated symptoms of each. Ebstein patients are also at risk for atrial arrhythmias, due to the atrial enlargement intrinsic to the anatomy, as well as the presence of potential accessory pathways. Arrhythmias are generally poorly tolerated, particularly in the setting of ventricular dysfunction. Cyanosis may also be present in Ebstein patients, due to the common occurrence of atrial communications, which can exacerbate other symptoms of heart failure. Treatment of heart failure can be through pharmacologic and procedural interventions, depending on the underlying cause of heart failure. While early heart failure symptoms may be treated with medical management, most Ebstein patients will require surgery. Various surgical and catheter-based interventions targeting the tricuspid valve and the atrialized right ventricular tissue have been developed to help treat the underlying cause of the heart failure. The optimal timing of transcatheter and surgical intervention in the Ebstein patient to prevent or treat heart failure needs further study.
Similar content being viewed by others
References
Hugh D, Allen DJD, Robert E, Shaddy TF (2013) Feltes Ebstein’s anomaly, congenital tricuspid valve regurgitation, and dysplasia. Lippincott Williams & Wilkins, a Wolters Kluwer business, Philadelphia
Brickner ME, Hillis LD, Lange RA (2000) Congenital heart disease in adults. Second of two parts. N Engl J Med 342:334–342
Attenhofer Jost CH, Connolly HM, Dearani JA, Edwards WD, Danielson GK (2007) Ebstein’s anomaly. Circulation 115:277–285
Gurvitz M, Stout K (2007) Ebstein’s anomaly of the tricuspid valve. Curr Cardiol Rep 9:336–342
Attenhofer Jost CH, Connolly HM, Edwards WD, Hayes D, Warnes CA, Danielson GK (2005) Ebstein’s anomaly - review of a multifaceted congenital cardiac condition. Swiss Med Wkly 135:269–281
Daliento L, Angelini A, Ho SY, Frescura C, Turrini P, Baratella MC, Thiene G, Anderson RH (1997) Angiographic and morphologic features of the left ventricle in Ebstein’s malformation. Am J Cardiol 80:1051–1059
Benson LN, Child JS, Schwaiger M, Perloff JK, Schelbert HR (1987) Left ventricular geometry and function in adults with Ebstein’s anomaly of the tricuspid valve. Circulation 75:353–359
Castaneda-Zuniga W, Nath HP, Moller JH, Edwards JE (1982) Left-sided anomalies in Ebstein’s malformation of the tricuspid valve. Pediatr Cardiol 3:181–185
Anderson KR, Lie JT (1979) The right ventricular myocardium in Ebstein’s anomaly: a morphometric histopathologic study. Mayo Clin Proc 54:181–184
Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, Crumb SR, Dearani JA, Fuller S, Gurvitz M, Khairy P, Landzberg MJ, Saidi A, Valente AM, van Hare G (2019) 2018 AHA/ACC Guideline for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 73:e81–e192
Nora JJ, Nora AH, Toews WH (1974) Letter: Lithium, Ebstein’s anomaly, and other congenital heart defects. Lancet (London, England) 2:594–595
Cohen LS, Friedman JM, Jefferson JW, Johnson EM, Weiner ML (1994) A reevaluation of risk of in utero exposure to lithium. Jama 271:146–150
Boyle B, Garne E, Loane M, Addor MC, Arriola L, Cavero-Carbonell C, Gatt M, Lelong N, Lynch C, Nelen V, Neville AJ, O'Mahony M, Pierini A, Rissmann A, Tucker D, Zymak-Zakutnia N, Dolk H (2017) The changing epidemiology of Ebstein’s anomaly and its relationship with maternal mental health conditions: a European registry-based study. Cardiol Young 27:677–685
Benson DW, Silberbach GM, Kavanaugh-McHugh A, Cottrill C, Zhang Y, Riggs S, Smalls O, Johnson MC, Watson MS, Seidman JG, Seidman CE, Plowden J, Kugler JD (1999) Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest 104:1567–1573
Yatsenko SA, Yatsenko AN, Szigeti K et al (2004) Interstitial deletion of 10p and atrial septal defect in DiGeorge 2 syndrome. Clin Genet 66:128–136
Yang H, Lee CL, Young DC, Shortliffe M, Yu W, Wright JR (2004) A rare case of interstitial del(1)(p34.3p36.11) diagnosed prenatally. Fetal Pediatr Pathol 23:251–255
Vermeer AM, van Engelen K, Postma AV et al (2013) Ebstein anomaly associated with left ventricular noncompaction: an autosomal dominant condition that can be caused by mutations in MYH7. Am J Med Genet C Semin Med Genet 163c:178–184
Bettinelli AL, Mulder TJ, Funke BH, Lafferty KA, Longo SA, Niyazov DM (2013) Familial Ebstein anomaly, left ventricular hypertrabeculation, and ventricular septal defect associated with a MYH7 mutation. Am J Med Genet A 161a:3187–3190
Attie F, Rosas M, Rijlaarsdam M, Buendia A, Zabal C, Kuri J, Granados N (2000) The adult patient with Ebstein anomaly. Outcome in 72 unoperated patients. Medicine 79:27–36
Watson H (1974) Natural history of Ebstein’s anomaly of tricuspid valve in childhood and adolescence. An international co-operative study of 505 cases. Br Heart J 36:417–427
Celermajer DS, Bull C, Till JA, Cullen S, Vassillikos VP, Sullivan ID, Allan L, Nihoyannopoulos P, Somerville J, Deanfield JE (1994) Ebstein’s anomaly: presentation and outcome from fetus to adult. J Am Coll Cardiol 23:170–176
Bialostozky D, Horwitz S, Espino-Vela J (1972) Ebstein’s malformation of the tricuspid valve. A review of 65 cases. Am J Cardiol 29:826–836
Giuliani ER, Fuster V, Brandenburg RO, Mair DD (1979) Ebstein's anomaly: the clinical features and natural history of Ebstein’s anomaly of the tricuspid valve. Mayo Clin Proc 54:163–173
Inai K, Nakanishi T, Mori Y, Tomimatsu H, Nakazawa M (2004) Left ventricular diastolic dysfunction in Ebstein’s anomaly. Am J Cardiol 93:255–258
Larissa Biolchini FG, Furtado I, Gusmão W, Veiga H, Paolino B (2018) Association between Ebstein Anomaly and Coronary Artery Disease: A Report Case. J Pharm Pharmacol 6:7
Delhaas T, Sarvaas GJ, Rijlaarsdam ME et al (2010) A multicenter, long-term study on arrhythmias in children with Ebstein anomaly. Pediatr Cardiol 31:229–233
Obioha-Ngwu O, Milliez P, Richardson A, Pittaro M, Josephson ME (2001) Ventricular tachycardia in Ebstein’s anomaly. Circulation 104:E92–E94
Frescura C, Angelini A, Daliento L, Thiene G (2000) Morphological aspects of Ebstein’s anomaly in adults. Thorac Cardiovasc Surg 48:203–208
Hebe J (2000) Ebstein’s anomaly in adults. Arrhythmias: diagnosis and therapeutic approach. Thorac Cardiovasc Surg 48:214–219
Smith WM, Gallagher JJ, Kerr CR, Sealy WC, Kasell JH, Benson DW Jr, Reiter MJ, Sterba R, Grant AO (1982) The electrophysiologic basis and management of symptomatic recurrent tachycardia in patients with Ebstein’s anomaly of the tricuspid valve. Am J Cardiol 49:1223–1234
Oh JK, Holmes DR Jr, Hayes DL, Porter CB, Danielson GK (1985) Cardiac arrhythmias in patients with surgical repair of Ebstein's anomaly. J Am Coll Cardiol 6:1351–1357
Wei W, Zhan X, Xue Y et al (2014) Features of accessory pathways in adult Ebstein's anomaly. Europace 16:1619–1625
Frankish K, Daly M, Greenslade J, Denekamp S, Chapman A, Lainchbury J, Melton I, Hooks D, Crozier I (2014) Electrophysiology assessment and radiofrequency ablation of arrhythmias in adult patients with congenital heart defects: the Christchurch experience. N Z Med J 127:88–96
Dearani JA, Danielson GK (2000) Congenital heart surgery nomenclature and database project: Ebstein’s anomaly and tricuspid valve disease. Ann Thorac Surg 69:S106–S117
Arya P, Beroukhim R (2014) Ebstein anomaly: assessment, management, and timing of intervention. Curr Treat Options Cardiovasc Med 16:338
Sun JPYX, Rangosch AN, Merlino JD (2010) Practical handbook of echocardiography: 101 case studies. Wiley-Blackwell, Oxford
Oechslin E, Buchholz S, Jenni R (2000) Ebstein’s anomaly in adults: Doppler-echocardiographic evaluation. Thorac Cardiovasc Surg 48:209–213
Yalonetsky S, Tobler D, Greutmann M, Crean AM, Wintersperger BJ, Nguyen ET, Oechslin EN, Silversides CK, Wald RM (2011) Cardiac magnetic resonance imaging and the assessment of ebstein anomaly in adults. Am J Cardiol 107:767–773
Steinmetz M, Usenbenz S, Kowallick JT et al (2017) Left ventricular synchrony, torsion, and recoil mechanics in Ebstein’s anomaly: insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 19:101
Trojnarska O, Szyszka A, Gwizdala A et al (2006) Adults with Ebstein’s anomaly--cardiopulmonary exercise testing and BNP levels exercise capacity and BNP in adults with Ebstein's anomaly. Int J Cardiol 111:92–97
Kempny A, Dimopoulos K, Uebing A, Moceri P, Swan L, Gatzoulis MA, Diller GP (2012) Reference values for exercise limitations among adults with congenital heart disease. Relation to activities of daily life--single Centre experience and review of published data. Eur Heart J 33:1386–1396
Radojevic J, Inuzuka R, Alonso-Gonzalez R et al (2013) Peak oxygen uptake correlates with disease severity and predicts outcome in adult patients with Ebstein's anomaly of the tricuspid valve. Int J Cardiol 163:305–308
Diller GP, Dimopoulos K, Okonko D, Li W, Babu-Narayan SV, Broberg CS, Johansson B, Bouzas B, Mullen MJ, Poole-Wilson PA, Francis DP, Gatzoulis MA (2005) Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation 112:828–835
Kipps AK, Graham DA, Lewis E, Marx GR, Banka P, Rhodes J (2012) Natural history of exercise function in patients with Ebstein anomaly: a serial study. Am Heart J 163:486–491
Kimberly Holst NMA, Joseph AD. Diagnosis and management of adult congenital heart disease. III ed
Dinardo JA (2013) Heart failure associated with adult congenital heart disease. Semin Cardiothorac Vasc Anesth 17:44–54
Shaddy RE, Webb G (2008) Applying heart failure guidelines to adult congenital heart disease patients. Expert Rev Cardiovasc Ther 6:165–174
Yang H, Bouma BJ, Mulder BJM (2017) Is initiating NOACs for atrial arrhythmias safe in adults with congenital heart disease? Cardiovasc Drugs Ther 31:413–417
Hernandez-Madrid A, Paul T, Abrams D et al (2018) Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace 20:1719–1753
Mrad Agua K, Burri M, Cleuziou J et al (2019) Preoperative predictability of right ventricular failure following surgery for Ebstein’s anomaly. Eur J Cardiothorac Surg 55:1187–1193
Stulak JM, Dearani JA, Danielson GK (2007) Surgical management of Ebstein’s anomaly. Semin Thor Cardiovasc Surg Pediatr Card Surg Annu:105–111
Dearani JA, Oleary PW, Danielson GK (2006) Surgical treatment of Ebstein’s malformation: state of the art in 2006. Cardiol Young 16(Suppl 3):12–20
Dearani JA, Said SM, O'Leary PW, Burkhart HM, Barnes RD, Cetta F (2013) Anatomic repair of Ebstein’s malformation: lessons learned with cone reconstruction. Ann Thorac Surg 95:220–226 discussion 226-8
Silva JP, Baumgratz JF, Fonseca L et al (2004) Ebstein’s anomaly: results of the conic reconstruction of the tricuspid valve. Arq Bras Cardiol 82:212–216
Mainwaring RD, Rosenblatt TR, Lui GK, Ma M, Hanley FL (2019) Surgical repair of Ebstein’s anomaly utilizing a bicuspidization approach. Ann Thorac Surg
Dearani JA, Mora BN, Nelson TJ, Haile DT, O'Leary PW (2015) Ebstein anomaly review: what’s now, what’s next? Expert Rev Cardiovasc Ther 13:1101–1109
Brown ML, Dearani JA, Danielson GK, Cetta F, Connolly HM, Warnes CA, Li Z, Hodge DO, Driscoll DJ (2008) Effect of operation for Ebstein anomaly on left ventricular function. Am J Cardiol 102:1724–1727
Attenhofer Jost CH, Connolly HM, Scott CG, Burkhart HM, Warnes CA, Dearani JA (2012) Outcome of cardiac surgery in patients 50 years of age or older with Ebstein anomaly: survival and functional improvement. J Am Coll Cardiol 59:2101–2106
Brown ML, Dearani JA, Danielson GK, Cetta F, Connolly HM, Warnes CA, Li Z, Hodge DO, Driscoll DJ (2009) Comparison of the outcome of porcine bioprosthetic versus mechanical prosthetic replacement of the tricuspid valve in the Ebstein anomaly. Am J Cardiol 103:555–561
Said SM, Burkhart HM, Schaff HV, Johnson JN, Connolly HM, Dearani JA (2014) When should a mechanical tricuspid valve replacement be considered? J Thorac Cardiovasc Surg 148:603–608
Author information
Authors and Affiliations
Corresponding author
Additional information
Key concepts
1. Ebstein anomaly encompasses a wide range of anatomic variations and severity. There is a bimodal distribution of presentation, with neonates presenting with cyanosis and heart failure, and adults frequently presenting with arrhythmias.
2. Patients can have left or right ventricular failure, and management strategies are unique to the particular cause.
3. Arrhythmia management is of crucial importance in patients with Ebstein anomaly, as patients may not tolerate a non-sinus rhythm well, particularly in the setting of ventricular dysfunction.
4. Atrial communications are common, and require thoughtfulness regarding management, as well as management of other issues in their presence.
5. There are many different strategies for surgical repair, and choice depends on the anatomy of the patient, as well as the expertise of the surgeon.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Schultz, K., Haeffele, C.L. Heart failure in the adult Ebstein patient. Heart Fail Rev 25, 623–632 (2020). https://doi.org/10.1007/s10741-020-09930-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10741-020-09930-2